4 hrs ago | Freshnews
Hepatitis Awareness: Bringing Attention to a Silent Epidemic
Viral hepatitis is an asymptomatic disease affecting more than 5.3 million Americans.
5 hrs ago | Live Science
Hepatitis C: A 21st Century Success Story
Hepatitis C has been called a silent epidemic: As the most common blood-borne viral infection in the country, it affects more than 7 million Americans - yet, most don't know they have it.
6 hrs ago | Las Vegas Review Journal
Judge admonishes prosecutor in hepatitis C case
A request for a mistrial from Dr. Dipak Desai's defense attorney was not granted.
7 hrs ago | HIV and Hepatitis
DDW 2013: Does Treating Herpes Help Suppress Hepatitis C Virus?
Treating herpes simplex virus type 2 with valacyclovir was associated with a substantial reduction in plasma hepatitis C virus levels in dually-infected individuals, according to a small study presented at the Digestive Disease Week conference this week in Orlando.
8 hrs ago | OttawaHerald.com
County concerned by Hepatitis C rise in Baby Boomers
In the first four months of the year, Franklin County already reported 63 percent of the number of Hepatitis C cases identified in 2012, significantly more than in other years, Midge Ransom, Franklin County health department director, said.
13 hrs ago | Charleston Business Journal
North Charleston spinal care center cooperating with DHEC
The Tri-County Spinal Care Center continues to provide noninvasive care and is cooperating with the S.C. Department of Health and Environmental Control as it looks into how three patients who were treated at the clinic contracted hepatitis B. "We are surprised and very concerned for our patients," said Cameron Wills, a chiropractic physician for ... (more)
20 hrs ago | Information Technology
European Medicines Agency Validates Gilead's Marketing Application...
Gilead Sciences, Inc. today announced that the company's Marketing Authorisation Application for sofosbuvir, a once-daily oral nucleotide analogue inhibitor for the treatment of chronic hepatitis C virus infection, which was submitted to the European Medicines Agency on April 17, 2013, has been fully validated and is now under assessment.
Janssen Phase III Hepatitis C Drug Shows Sustained Virologic Response
Janssen R&D Ireland today announced primary efficacy and safety results from the global Phase 3 PROMISE study demonstrating that use of the investigational protease inhibitor simeprevir led to sustained virologic response 12 weeks after the end of treatment in 79 percent of treatment-experienced genotype 1 chronic hepatitis C adult patients with ... (more)
Catskill Hospital warns that insulin pens may have been reused
Catskill Regional Medical Center issued a warning Tuesday that some patients might have been exposed to HIV and hepatitis by the shared use of insulin injection pens.
3 have hepatitis B after injections at SC clinic
The Department of Health and Environmental Control says all three people received spinal injections with common medications on the same dates in February.
Nurse fired over link to hepatitis C outbreak sues Exeter Hospital
A former Exeter Hospital nurse and roommate of the man allegedly responsible for the Exeter Hospital hepatitis C outbreak is suing the hospital for wrongful termination.
Pukay: Vaccination recommended to combat resurgence of leptospirosis
Question: Is leptospirosis enough of a problem to warrant annual vaccination? How do I determine if my dog needs to be vaccinated against this disease? Answer: Leptospirosis has become significantly more prevalent in Canada over the past few years.
Preschools may get right to bar unvaccinated children
Opponents of vaccinations say they can be unsafe and cause serious side-effects, weaken the immune system, and can cause autism.
Sofosbuvir for Hep C genotype 2 or 3 in patients without treatment options
This week's issue of the New England Journal of Medicine investigates the use of sofosbuvir for Hepatitis C genotype 2 or 3 in patients without treatment options.
Health Canada is responsible for protecting Canadians from unsafe or ineffective products.
Pharmaceutical advances offer new options for health outcomes
Research presented at Digestive Disease Week explores pharmaceutical advances for treating irritable bowel syndrome with diarrhea and hepatitis C. An international study holds promising results for patients suffering from IBS-D. In the phase II study, researchers found that the drug ibodutant significantly improved symptoms in more than 50 percent ... (more)
GBI Research estimated the travel vaccines market in the top seven markets to be worth $1,343m in 2012, having grown at a Compound Annual Growth Rate of 11% from 2007.
Get Vaccinated, Cobb Health Officials Say
Cobb & Douglas Public Health officials are encouraging parents and caregivers to get Hepatitis A and B vaccines for their children.
R.I. health director urges baby boomers to get Hepatitis C test
Rhode Island's health department is encouraging baby boomers to get tested for Hepatitis C, saying adults born between 1945 and 1965 are five times more likely to contract the disease.
KCMO Health Department to Hold Special Hepatitis C Testing Clinic
Hepatitis C is a liver disease that is spread when blood from an infected person enters another person's body.